Not available
Quote | iCad Inc. (NASDAQ:ICAD)
Last: | $1.47 |
---|---|
Change Percent: | -3.97% |
Open: | $1.5388 |
Close: | $1.47 |
High: | $1.5388 |
Low: | $1.43 |
Volume: | 138,193 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | iCad Inc. (NASDAQ:ICAD)
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering radiologists in early breast cancer detection New partnership with Densitas provides end-to-end breast health solution ensuring ever...
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluation Expands access to iCAD’s AI-powered ProFound Breast Health Suite and Densitas’...
Message Board Posts | iCad Inc. (NASDAQ:ICAD)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ICAD News Article - iCAD's Breast AI Suite Empowers Customers to Lead the Way in Suppo | whytestocks | investorshangout | 03/23/2023 5:10:52 PM |
Looks like a new 10 year low. | willlbone | investorshub | 03/14/2023 2:07:04 PM |
$iCAD looking forward to the start of quarter | Netcool | investorshub | 01/07/2023 11:35:56 PM |
Insider buying today | dletizia | investorshub | 01/06/2023 1:39:43 AM |
On Dec. 5, U.S. stocks were dragged down | dletizia | investorshub | 12/12/2022 3:00:27 PM |
News, Short Squeeze, Breakout and More Instantly...
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering radiologists in early breast cancer detection New partnership with Densitas provides end-to-end breast health solution ensuring ever...
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluation Expands access to iCAD’s AI-powered ProFound Breast Health Suite and Densitas’...
NASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its AI-powered solution effectively uncovers calcium deposits in the breast vessels, a sign of possible c...